Petros Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Petros Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3% to $5,822,388. The net income raised on -$8,163,188 and profit margin reached -140%. Total operating expenses were $17,808,532.
Profit Margin
| 2019 | 15.57M | -32.51M | -208.71% |
|---|---|---|---|
| 2020 | 9.55M | -20.58M | -215.35% |
| 2021 | 7.81M | -9.35M | -119.77% |
| 2022 | 5.99M | -27.03M | -451.22% |
| 2023 | 5.82M | -8.16M | -140.2% |
PTPI Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 5.82M | 5.99M | 7.81M | 9.55M | 15.57M |
Cost of revenue | 1.63M | 2.28M | 1.59M | 4.04M | 7.42M |
Gross profit | 4.19M | 3.70M | 6.21M | 5.51M | 8.15M |
Operating exp. | |||||
Research and development | 2.40M | 1.74M | 1.78M | 459.63K | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.80M | 19.54M | 24.25M | 22.79M | 25.01M |
Operating income | -13.61M | -15.84M | -18.04M | -17.28M | -16.86M |
Other income (expenses), net | 5.45M | -4.19M | 9.06M | -4.73M | -16.28M |
Income before tax | -8.16M | -20.03M | -8.98M | -22.01M | -33.15M |
Income tax expense | 0 | 7M | 368.66K | -1.42M | -645.86K |
Net income | -8.16M | -27.03M | -9.35M | -20.58M | -32.51M |
Earnings per share | |||||
Basic EPS | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 |
Diluted EPS | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 |
| Data source | Data source | Data source | Data source |